Search

The Connection Between Viruses and Other Factors Contributing to the Development of MS

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers
and The France Foundation.

Release Date: April 14, 2023
Expiration Date: April 13, 2024
TARGET AUDIENCE:

This educational activity is intended for neurologists, multiple sclerosis (MS) subspecialists, primary care clinicians, advanced practice clinicians, nurses, pharmacists, and other members of the comprehensive MS care team.

PROGRAM OVERVIEW:

This brief module will help you identify comorbid risk factors for MS progressions and will also review the efficacy and safety for current and emerging DMT agents for MS.

LEARNING OBJECTIVES

Upon completion of this course, the learners should be able to:

  • Identify comorbid risk factors for MS progression in order to apply appropriate strategies
  • Review efficacy and safety data for current and emerging DMT agents for MS
FACULTY

Michael Levy, MD, PhD
Associate Professor, Harvard Medical School
Director, Neuroimmunology Clinic and Research Laboratory
Research Director, Division of Neuroimmunology & Neuroinfectious Disease
Department of Neurology, Massachusetts General Hospital
Boston, Massachusetts

PLANNING COMMITTEE

Michael Levy, MD, PhD
Associate Professor, Harvard Medical School
Director, Neuroimmunology Clinic and Research Laboratory
Research Director, Division of Neuroimmunology & Neuroinfectious Disease
Department of Neurology, Massachusetts General Hospital
Boston, Massachusetts

Margaret Das, PhD
Senior Medical Writer
The France Foundation
Old Lyme, Connecticut

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and The France Foundation. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT DESIGNATION

Physicians
The Consortium of Multiple Sclerosis Centers designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The Consortium of Multiple Sclerosis Centers designates this activity for 0.50 contact hours.

All other healthcare professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The Consortium of Multiple Sclerosis Centers (CMSC) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity CMSC and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs.

Furthermore, CMSC and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and TFF are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

DISCLOSURE OF UNLABELED USE

CMSC and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. CMSC and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGEMENT

This activity is supported by an educational grant from Novartis.

DISCLAIMER

The Consortium of Multiple Sclerosis Centers and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The Consortium of Multiple Sclerosis Centers, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.

COPYRIGHT INFORMATION

Copyright © 2023 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation’s prior written permission
PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual’s consent, except when such information is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at https://www.francefoundation.com/privacy.

CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or [email protected].

INSTRUCTIONS FOR PARTICIPATION & REQUESTING CREDIT

There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.

Credit Fulfillment
If you are requesting AMA credits, ANCC credits, or a certificate of participation your certificate will be available for download

Technical Requirements
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.

Additionally, this site and its activities are best viewed using the latest operating system for your device.

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts